New insights into development and mortality of <scp>COVID‐19</scp>‐associated pulmonary aspergillosis in a homogenous cohort of 1161 intensive care patients

Abstract

We observed a low but likely underestimated prevalence of CAPA in our study. CAPA is a disease with high mortality and diabetes is a significant factor for its development while ARDS and pulse glucocorticoid treatment are significant factors for its mortality. Cellular immune dysregulation may have a central role in CAPA from its development to mortality.